Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rhea-AI Summary

Rigel (Nasdaq: RIGL) will report third quarter 2025 financial results after market close on Tuesday, November 4, 2025. Senior management will host a live conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss results and provide a business update. Participants can join via domestic dial-in 877-407-3088 or international 201-389-0927, and the webcast (with slides) will be available on the company Investor Relations website at www.rigel.com.

The webcast will be archived for 90 days after the call. Rigel is a biotechnology company focused on therapies for hematologic disorders and cancer, headquartered in South San Francisco.

News Market Reaction – RIGL

-0.98%

32 alerts

-0.98% Session close to close

+3.1% Peak in 5 hr 33 min

$568.25M Market Cap

0.9x Rel. Volume

In the Oct 29 session, RIGL declined 0.98%, reflecting a mild negative market reaction. Argus tracked a peak move of +3.1% during that session. Our momentum scanner triggered 32 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on Tuesday, November 4, 2025. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com 

Media:
David Rosen
Argot Partners
Phone: 646.461.6387
Email: david.rosen@argotpartners.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-third-quarter-2025-financial-results-and-business-update-302597734.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When will Rigel (RIGL) report third quarter 2025 results?

Rigel will report Q3 2025 results after market close on Tuesday, November 4, 2025.

What time is the Rigel (RIGL) earnings conference call and webcast on November 4, 2025?

The live conference call and webcast start at 4:30 p.m. ET (1:30 p.m. PT) on November 4, 2025.

How can investors join Rigel's (RIGL) November 4, 2025 earnings call?

Dial 877-407-3088 (U.S.) or 201-389-0927 (international), or join the live webcast on www.rigel.com.

Will the Rigel (RIGL) webcast of the Q3 2025 call be available after the event?

Yes, the webcast and slides will be archived and available for replay on Rigel's website for 90 days after the call.

Where is Rigel (RIGL) headquartered and what does the company do?

Rigel is based in South San Francisco, California and develops therapies for hematologic disorders and cancer.